Continued support for an interdisciplinary Pharmacology Graduate Training Program, currently in its 29th year, is proposed to prepare students for productive careers in disciplines where fundamental knowledge of quantitative and systems pharmacology is required. Alumni from this training program have gone on to academia, industry, regulatory science and consulting, to name a few of the variety of opportunities training in pharmacology provides. Our Predoctoral Training Program trains Pharmacology Graduate Group (PGG) students in classic principles of pharmacology including pharmacokinetics, dynamics, drug- receptor interactions as well as the newly emerging fields of proteomics and metabalomics. The PGG is supported by an interdepartmental group of 71 faculty from 20 departments in 4 Schools of the University of Pennsylvania. The Office of Biomedical Graduate Studies (BGS) ensures curricular development, quality control and uniform admission standards across all Graduate Groups, including PGG. Direct management of the Pharmacology Training Program is done by a five-person Advisory Committee that, in corrdination with the Executive Committee of the PGG, defines and reviews policy and selects trainees. Pharmacology Training Grant Faculty membership is governed by three criteria: (1) expertise in a relevant field of study, (2) significant contribution to training, and (3) extramura funding to support trainees. Admission of students to Graduate Programs is a tiered decision, first by the PGG, then by a BGS-wide admissions committee. Subsequent apppointment to the pharmacology training grant is decided by its Advisory Committee. Support for each trainee will encompass their first 12-24 months in thesis lab. Trainees must re-apply after the first 12 months and while most students are re- appointed for a second 12-month period, this intermediate evaluation enhances progress and productivity. Prior to appointment, students must successfully complete required courses in Cell and Molecular Biology, Fundamentals of Pharmacology and Medical pharmacology and Human physiology. Coursework extends over 1.5-2 years plus three lab rotations. All students will take a yearly course on the responsible conduct of scientific research. Students will also receive training through seminars, journal clubs, annual retreats, scientific meetings, oral and poster presentations, and social events that encourage interactions. Successful completion of a comprehensive "Candidacy" examination marks the start of independent research toward the dissertation. Thesis research is conducted under the supervision of a faculty advisor and is monitored by a thesis committee and the PGG Academic Review Committee. The dissertation defense takes place when the thesis advisor and committee concur that the body of work is complete. Based on the number of potential trainees, we request support for 12 predoctoral trainees/year for the next 5 years.

Public Health Relevance

This Predoctoral Pharmacology Training Program includes education and research opportunities to provide a multifaceted doctoral program that incorporates cutting-edge research and a curriculum that provides both depth and breadth in many areas of Pharmacology. It is designed to prepare students as leaders in pharmacological sciences in academia, government, and industry.

Agency
National Institute of Health (NIH)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM008076-30
Application #
8666265
Study Section
(TWD)
Program Officer
Okita, Richard T
Project Start
Project End
Budget Start
Budget End
Support Year
30
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Snyder, Nathaniel W; Golin-Bisello, Franca; Gao, Yang et al. (2015) 15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways. Chem Biol Interact 234:144-53
Jackson, Joshua G; O'Donnell, John C; Krizman, Elizabeth et al. (2015) Displacing hexokinase from mitochondrial voltage-dependent anion channel impairs GLT-1-mediated glutamate uptake but does not disrupt interactions between GLT-1 and mitochondrial proteins. J Neurosci Res 93:999-1008
Christian, Abigail J; Alferiev, Ivan S; Connolly, Jeanne M et al. (2014) The effects of the covalent attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl)propyl amine to glutaraldehyde pre-treated bovine pericardium on structural degeneration, oxidative modification and calcification of rat subdermal implants. J Biomed Mater Res A :
Jackson, Joshua G; O'Donnell, John C; Takano, Hajime et al. (2014) Neuronal activity and glutamate uptake decrease mitochondrial mobility in astrocytes and position mitochondria near glutamate transporters. J Neurosci 34:1613-24
Step, Sonia E; Lim, Hee-Woong; Marinis, Jill M et al. (2014) Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPAR?-driven enhancers. Genes Dev 28:1018-28
Chen, Edward P; Markosyan, Nune; Connolly, Emma et al. (2014) Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function. Carcinogenesis 35:1788-97
Arlauckas, Sean P; Popov, Anatoliy V; Delikatny, Edward J (2014) Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine. Mol Cancer Ther 13:2149-58
Jochems, Jeanine; Boulden, Janette; Lee, Bridgin G et al. (2014) Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology 39:389-400
Ashare, Rebecca L; Falcone, Mary; Lerman, Caryn (2014) Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology 76 Pt B:581-91
Christian, Abigail J; Lin, Hongqiao; Alferiev, Ivan S et al. (2014) The susceptibility of bioprosthetic heart valve leaflets to oxidation. Biomaterials 35:2097-102

Showing the most recent 10 out of 29 publications